Back to Journals » Blood and Lymphatic Cancer: Targets and Therapy
Blood and Lymphatic Cancer: Targets and Therapy
Editor-in-Chief: Dr Wilson Gonsalves
An international, peer reviewed, open access journal focusing on blood and lymphatic cancer research, identification of therapeutic targets, and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival, and quality of life for the cancer patient.
The journal welcomes submitted papers covering original research, basic science, clinical & epidemiological studies, reviews & evaluations, guidelines, expert opinion and commentary, case reports, and extended reports.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
Articles:
- View all (143)
- Volume 16, 2026 (17)
- Volume 15, 2025 (19)
- Volume 14, 2024 (6)
- Volume 13, 2023 (7)
- Volume 12, 2022 (12)
- Volume 11, 2021 (6)
- Volume 10, 2020 (2)
- Volume 9, 2019 (7)
- Volume 8, 2018 (7)
- Volume 7, 2017 (8)
- Volume 6, 2016 (5)
- Volume 5, 2015 (11)
- Volume 4, 2014 (13)
- Volume 3, 2013 (6)
- Volume 2, 2012 (12)
- Volume 1, 2011 (5)
Latest articles:
- 5 records -
Metabolic Subtypes Predict Treatment Response in Acute Myeloid Leukemia: A Pilot Study
Yan C, Huang Y, Cai Q, Li X, Yang Q, Feng G, Yang H, Chen Y, Hu J
Blood and Lymphatic Cancer: Targets and Therapy 2026, 16:612305
Published Date: 16 June 2026
A Risk Model Using Refined Disease Risk Index and 1-Month NK-Cell Count for Relapse in Children and Adults with T-ALL/LBL After Myeloablative Umbilical Cord Blood Transplantation
Zhao N, Chi R, Song K, Wu Y, Yan B, Wang D, Tang B, Zhu X
Blood and Lymphatic Cancer: Targets and Therapy 2026, 16:582933
Published Date: 22 May 2026
Exploring the Bone Marrow Microenvironment as a Therapeutic Barrier and Targetable Source of Crosstalk in Acute Myeloid Leukemia
Kolosova A, Mould IA, Pepper C, Mitchell S, Pepper AG, Ladikou EE, Simoes FA
Blood and Lymphatic Cancer: Targets and Therapy 2026, 16:511758
Published Date: 19 May 2026
Short-Term Longitudinal Analysis of Gut Microbiota Dynamics During Anti-CD19 CAR-T Cell Therapy in Diffuse Large B-Cell Lymphoma Patients
Shen Z, Xing X, Rong K, Geng Z, Yang N, Xu L, Ge H, Sang W
Blood and Lymphatic Cancer: Targets and Therapy 2026, 16:598958
Published Date: 1 May 2026
Poor Outcome of Pediatric Patients with Acute Lymphoblastic Leukemia Harboring Low P16 Deletion Ratio: A Post-Hoc Analysis from a Prospective Cohort
Qiu KY, Liao XY, Chen HL, Zheng H, Fang JP, Zhou DH
Blood and Lymphatic Cancer: Targets and Therapy 2026, 16:592290
Published Date: 30 April 2026
